GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Glaxosmithkline Pharmaceuticals' standalone net profit jumped 39.11% to Rs 181.65 crore in Q1 FY25 as compared to Rs 130.58 crore posted in Q1 FY24.